Thomas Tu; Magdalena A. Budzinska; Annette E. Maczurek; Robert Cheng; Anna Di Bartolomeo; Fiona J. Warner; Geoffrey William McCaughan; Susan V. McLennan; Nicholas Adam Shackel

Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: Current status and future prospects

World Journal of Gastroenterology 20(12) (2014)

Seow Chong Lee

Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection

World Journal of Gastroenterology 19(47) (2013)

Tao Lu

Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution's experience with 398 consecutive patients

Hepatobiliary & pancreatic diseases international 13(2) (2014)

Zhenggui Du; Yonggang Wei; Ke-Fei Chen; Bo Li

Human cytidine deaminases facilitate hepatitis B virus evolution and link inflammation and hepatocellular carcinoma

Cancer Letters 343(2) (2013)

Yang Deng; Yan Du; Qi Zhang; Xue Na Han; Guangwen Cao

Hepatitis B virus treatment in hepatocellular carcinoma patients prolongs survival and reduces the risk of cancer recurrence

Clinical and Experimental Hepatology 4(3) (2018)

Monika Pazgan−Simon; Krzysztof Adam Simon; Ewa Jarowicz; Katarzyna Rotter; Anna Szymanek-Pasternak; Jolanta Zuwała−Jagiełło

LncRNA NKILA inhibits HBV replication by repressing NF-κB signalling activation

Virologica Sinica 39(1) (2023)

Xi Zhang; Yuanyuan Li; Chen Huan; Yubao Hou; Rujia Liu; Hongyun Shi; Peng Zhang; Baisong Zheng; Yingchao Wang; Hong Wang; Wenyan Zhang

MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase

Yonsei Medical Journal 61(6) (2020)

Xiukun Fei; Peipei Zhang; Yu Pan; Yuanyuan Liu

The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma

Cancer Letters 379(2) (2015)

Enze Jiang; Anna Junjie Shangguan; Shuangshuang Chen; Lin Tang; Shuang Zhao; Zhenghong Yu

Effect of nucleoside analog use in patients with hepatitis B virus‐related hepatocellular carcinoma

Hepatology Research 44(6) (2013)

Hiroki Nishikawa; Norihiro Nishijima; Akira Arimoto; Tadashi Inuzuka; Ryuichi Kita; Tōru Kimura; Yukio Osaki

Peg‐interferon and nucleos(t)ide analogue combination at inception of antiviral therapy improves both anti‐HBV efficacy and long‐term survival among HBV DNA‐positive hepatocellular carcinoma patients after hepatectomy/ablation

Journal of Viral Hepatitis 27(4) (2019)

Wenqian Qi; Qian Zhang; Yan Xu; Xu Wang; Yu Fan; Yonggui Zhang; Ping Zhao; Honghua Guo; Changyu Zhou; Zhe Wang; Yu Sun; Lin Liu; Wei Xuan; Jiangbin Wang

Application of hazard functions to investigate recurrence after curative-intent resection for hepatocellular carcinoma

HPB 25(2) (2022)

Henrique Araujo Lima; Laura Alaimo; Zachary J. Brown; Yutaka Endo; Zorays Moazzam; Diamantis I. Tsilimigras; Chanza Fahim Shaikh; Vívian Resende; Alfredo Guglielmi; Francesca Ratti; Luca Antonio Aldrighetti; Hugo P. Marques; Olivier Soubrane; Vincent W. T. Lam; George A. Poultsides; Irinel Popescu; Sorin Tiberiu Alexandrescu; Guillaume Martel; Thomas J. Hugh; Itaru Endo; Feng Shen; Timothy Michael Pawlik

Prognostic factors in patients with hepatitis B virus-related hepatocellular carcinoma undergoing nucleoside analog antiviral therapy

Oncology Letters 6(5) (2013)

Hiroki Nishikawa; Norihiro Nishijima; Akira Arimoto; Tadashi Inuzuka; Ryuichi Kita; Tōru Kimura; Yukio Osaki

DNA Polymerases as targets for gene therapy of hepatocellular carcinoma

BMC Cancer 15(1) (2015)

Hao Liu; Qun Wei; Jia Wang; Xiaoming Huang; Chunchun Li; Qiaoli Zheng; Jiang Cao; Zhenyu Jia

Role of TGF-β1 and C-Kit Mutations in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients: in vitro Study

Biochemistry (Moscow) 84(8) (2019)

Motawa E. El-Houseini; Ahmed Hamed Ismail; A A Abdelaal; AHMED H. EL-HABASHY; Zeinab Fathy Abdallah; M. Z. Mohamed; Mohamed S. El-Hadidi; William Chi Shing Cho; Hany M. Ahmed; Tamer A. Al‐Shafie

Long-term clinical benefit of Peg-IFNα and NAs sequential anti-viral therapy on HBV related HCC

Neoplasma 68(01) (2020)

Wen-Qian Qi; Qian Zhang; Xu Wang; Yan Xu; Ping Zhao; Honghua Guo; Changyu Zhou; Yu Sun; Lin Liu; Jiangbin Wang

Role of selected criteria and preventive chemotherapy in tumor recurrence after liver transplantation

Hepatobiliary & pancreatic diseases international 19(4) (2020)

Meixi Wang; Dong Chen; Yuanyuan Zhao; Bo Yang; Jipin Jiang; Fanjun Zeng; Lai Wei; Zhishui Chen

Cancer Evo-Dev, a novel hypothesis derived from studies on hepatitis B virus-induced carcinogenesis

Hepatoma Research 3(10) (2017)

Guangwen Cao

Different Faces of Hepatocellular Carcinoma as a Health Threat in 21st Century

Hepatitis Monthly 13(2) (2013)

Behzad Yeganeh; Mohammad Mostakhdem Hashemi; Fredrick J. de Serres; Marek Łoś; Saeid Ghavami

Challenges of incorporating gene expression data to predict HCC prognosis in the age of systems biology

World Journal of Gastroenterology 18(30) (2012)

Yan Du

Role of hsa_circ_0066966 in proliferation and migration of hepatitis B virus‑related liver cancer cells

Experimental and Therapeutic Medicine 23(1) (2021)

Yinghua Yuan; Xiaojin Yang; Desheng Xie

Cidan Capsule in Combination with Adjuvant Transarterial Chemoembolization Reduces Recurrence Rate after Curative Resection of Hepatocellular Carcinoma: A Multicenter, Randomized Controlled Trial

Chinese Journal of Integrative Medicine 29(1) (2022)

Donghai Zheng; Jiamei Yang; Jianxiong Wu; Shuqun Cheng; Shaogeng Zhang; Dong Wu; Aijun Li; Xiaohui Fu; Xun Li; Fu-chen Qi; Wei-hong Duan; Junhui Chen; Zhiying Yang; Lu Liang; Jin-xiong Zeng; Weida Zheng; Meng-Chao Wu